Anticoagulation in COVID-19: current concepts and controversies

Authors: http://orcid.org/0000-0002-3809-8926Atanu Chandra1, 6289Uddalak Chakraborty2, Shrestha Ghosh1, Sugata Dasgupta3 Abstract Rising incidence of thromboembolism secondary to COVID-19 has become a global concern, with several surveys reporting increased mortality rates. Thrombogenic potential of the…[...]

Read More

US case series study in children study looking at association of myocarditis with the Pfizer-BioNTech COVID-19 vaccine

Authors: byUK Science Media Centre|Published onAugust 10, 2021: Prof Peter Openshaw In this case series, 15 cases of myocarditis are described from a single paediatric referral centre in May, June…[...]

Read More

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

Authors: Pierre Kory, MD,1,*Gianfranco Umberto Meduri, MD,2Joseph Varon, MD,3Jose Iglesias, DO,4 and Paul E. Marik, MD5 Background: After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and…[...]

Read More